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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not
dynamic ankle foot orthotics (DAFO) improve gait in pediatric patients with spastic diplegic
cerebral palsy (CP).
STUDY DESIGN: Review of two randomized controlled trials with crossover from 2009 and
2015 and one blinded randomized controlled trial from 2006.
DATA SOURCES: All articles were presented in English and were taken from peer reviewed
sources using PubMed and Google Scholar. All articles were published between 2006-2016.
OUTCOMES: Outcomes of investigation measured are quantitative walking velocity measured
via gait analysis and functional ability during ambulation using the Gross Motor Function
Measurement-88 scoring system.
RESULTS: Wren et al found that there was a statistically significant increase in walking velocity
while wearing DAFOs when compared to walking barefoot and also with different type of ankle
foot orthoses. Bjornson et al found statistically significant improvements in the Gross Motor
Function Measurement-88 scores when wearing DAFOs than when barefoot or wearing a
simulated placebo device. Smith et al. found overall improvements in gait while wearing DAFOs
and an increase in velocity after consistent month-long use of DAFOs, but the increase was not
statistically significant.
CONCLUSIONS: These three studies show that DAFOs provide tangible benefit to individuals
with spastic diplegic cerebral palsy. All 3 studies showed overall gait or functional
improvements in those wearing dynamic ankle foot orthotics when compared against either
themselves or age-matched controls regardless of the length of time the devices were worn with
2 of the studies showing statistically significant results. Further research can help to further
clarify the efficacy of DAFOs within the pediatric population as a whole.
KEYWORDS: cerebral palsy, dynamic ankle foot orthotic
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INTRODUCTION
Cerebral palsy (CP) is an overarching term for a non-progressive group of congenital
neuromuscular conditions that present with universal themes of muscle hypo/hypertonicity and
abnormalities in movement and ambulation.1 It is often commonplace to see other symptoms, such
as cognitive delay, respiratory comorbidities and epilepsy in individuals with CP, but it is not a
requirement to have those features in order to make a diagnosis of cerebral palsy. One specific
type of cerebral palsy, spastic diplegic cerebral palsy, contains hypertonicity, spasticity and
movement challenges that are localized to the lower extremities bilaterally.1 Hypertonic muscles
in the lower extremities contribute to challenges in ambulation that may impair one’s ability to
ambulate, overall function and ultimately their quality of life.
Unfortunately, cerebral palsy is one of the most common congenital birth defects with an
incidence of 2.11 per 1000 births.2 While there are many types of CP, spastic diplegia is the most
common.2 Although it is not known exactly what mechanism causes CP, each case does have
one thing in common: brain injury immediately prior or during delivery that causes an anoxic or
hypoxic state leading to neuronal injury or death.3 Most individuals with cerebral palsy are born
premature and subsequently require specialized care within neonatal intensive care units due to
underdevelopment of critical structures, most commonly their lungs and its ability to produce
surfactant. Although non-progressive nor terminal, cerebral palsy does require additional
management throughout a person’s life in order to maintain functionality and quality of life.4
While the condition as a whole does not progress, symptomatic management is the main focus.
To achieve this, individuals with cerebral palsy must utilitze healthcare services more frequently
than the average individual. Data shows that pediatric patients with cerebral palsy visit outpatient
providers 2.2 times more and are hospitalized 4.3 more often than their able-bodied peers.5 In
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fact, it is estimated that it costs an extra $80,000 in addition to normal lifetime costs to care for
someone with cerebral palsy.6
There are no true diagnostic tests or studies that can diagnose cerebral palsy as a whole. It
is instead a clinical diagnosis that in the very young can be subtle. It is often not picked up until
individuals begin to miss age-related milestones that clinicians often suspect cerebral palsy.7 While
it is often a diagnosis of exclusion, the criteria to classify cerebral palsy are defined and uniform.
First, the amount of resting muscle tone that an individual has is evaluated to be either spastic
(hypertonic) or non-spastic (hypotonic).7 For spastic individuals, the body region affected is then
classified (diplegia, hemiplegia, or quadriplegia).7 Individuals with non-spastic CP are broken
down by whether their movements are voluntary, involuntary or involve their whole body (ataxia,
dyskinetic or athenoid).7
Much like there being no true diagnosis of CP of any type, there is no definitive treatment.
Instead this condition is treated solely symptomatically. By definition, spastic diplegic CP contains
hypertonic muscles (spastic) and affects the lower extremities bilaterally (diplegic) with little to
no involvement in the upper extremities. There are many different modalities employed to limit or
decrease one’s tone and improve overall function all with varying successes. While each treatment
is tailored to the severity of one’s spasticity, there are many types of standard treatments that can
be done for a patient ranging from physical therapy to stretching and strengthening, assistive
devices (crutches, wheelchairs, orthotics), medications to reduce spasms, and various types of
orthopedic surgery.4 Of all the treatments, one of the least invasive and most commonly employed
is the use of ankle foot orthotics. The orthotics are custom fitted to the patient and provide a
continuous stretch of specific muscle groups, while providing support.8 There are many different
variations of these orthotics that a clinician can prescribe for a patient to serve individual needs
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depending on their specific gait and muscle tone. Ankle foot orthotics can range from flexible
(dynamic), solid, adjustable or hinged at the talocalcaneal joint.8,9 One orthotic type used is a
dynamic ankle foot orthotic (DAFO), a non-hinged single piece flexible brace that provides
support at the malleoli, while still allowing a patient to ambulate through a full gait cycle.9
Dynamic ankle foot orthotics serve as a noninvasive way to augment other long term modalities
(i.e. surgery) in improving patient’s walking speed and ambulatory function.
OBJECTIVE:
The objective of this selective EBM review is to determine whether or not dynamic ankle
foot orthotics (DAFO) improve gait in pediatric patients with spastic diplegic cerebral palsy (CP).
METHODS:
Two randomized controlled trials with a crossover and a blinded randomized controlled
trial were chosen for review. The patient population selected for review was ambulatory patients
under the age of 18 years old with a diagnosis of spastic diplegic cerebral palsy. Interventions
employed included use of dynamic ankle foot orthotics bilaterally. Depending on the study,
subjects were either aged matched to controls or to themselves with appropriate washout periods.
Outcomes measured were patient oriented and focused on: ambulatory velocity and functional
changes in ambulation using the Gross Motor Function Measurement-88 objective scoring system.
Both Google Scholar and PubMed databases were utilized to select studies. Keywords used
to search were “cerebral palsy” and “dynamic ankle foot orthotics.” The three studies selected
were published in peer reviewed journals between 2006-2016 and all were written in English. In
general, inclusion criteria for all three studies was the same: ambulatory pediatric patients under
18 years old with a primary diagnosis of spastic diplegic cerebral palsy. Two of the three studies
provided the same exclusion criteria, subjects over 18 years of age and/or those that have
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undergone an orthopedic/neurosurgical or botulinum toxin A injection within 12 or 6 months of
participation, respectively. Detailed inclusion and exclusion criteria, as well as other individual
study characteristics, are provided in Table 1. The statistics reported in the studies and utilized for
the review were p-values, X2 and ANOVA.
Table 1. - Demographics & characteristics of included studies
Study

Type

Smith
(2009)9

RCT with
Crossover

Wren
(2015)10

RCT with
Crossover

# Pts

Age
Inclusion
(yrs.)
Criteria
15
Mean
-Age: ≤13 years
subjects age: 7.5 ± -Ambulate
2.9 years without assistive
20
devices
controls (Age
(crutches/cane
range not
etc.)
disclosed) - “Jump gait”
pattern of walking
-Baseline
GMFCS-88
Score: 1
-Ability to
dorsiflex ankle to
neural position on
PE

Exclusion
Criteria
1. Any
orthopedic or
neurological
surgical
intervention
within 12
months
2. Botulism
toxin A
injections
within 6
months

W/ Interventions
D
0
Daily use of
dynamic or
hinge ankle foot
orthotic for 4
weeks. Washout
period of 2
weeks. Daily
use of other
ankle foot
orthotic for 4
weeks

10
Ages:
subjects 4-12
years old

None
provided

0

-Age: 0-18 years
old -Crouch
and/or equinus
gait
-Baseline
GMFCS-88 Level
I—III

Wearing
dynamic ankle
foot orthotics
daily for 4
weeks, then
wearing ADRAFOs for
another 4 weeks
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Bjornson
11

(2006)

RCT with
Crossover
& Double
Blinding

23
Ages:
subjects 1.9-7.3
years old

-Age: 12-96
months
-GMFCS-88
levels 1-3
-Current use of
bilateral dynamic
foot orthotic with
free
plantarflexion
-Minimum
orthotic use of 4
hours per day for
at least one month

1.Orthopedic
or
neurological
surgical
intervention
within 12
months
2. Botulism
toxin A
injections
within 6
months

0

Wearing sock
covered DAFOs
and undergoing
GMFM scoring
2x and then
repeating test
with placebo
(sock cover
mimicking
DAFO)

OUTCOMES MEASURED:
This review examined both ambulatory velocity and changes in Gross Motor Function
Measurement – 88 (GMFCS-88) scores when using DAFOs bilaterally. Using a motion analysis
program to track, measure and video record body motion while ambulating, velocity was
calculated both with and without a DAFO. To measure GMFCS-88 scores, a licensed pediatric
physical therapist scored patients both with and without the device. This objective scoring system
scores patients by ability and ease to do a variety of specific functional motions (rolling, sitting,
crawling, kneeling, standing, walking, running and jumping).
RESULTS:
Smith et al., conducted a randomized controlled trial age matched comparing 15 subjects
and 20 age matched controls that were 13 years of age or younger who did not use any assistive
devices to ambulate on a daily basis.9 The authors reported a mean age of 7.5 ± 2.9 years of age.
Additional inclusion and exclusion criteria are provided in Table 1. This trial examined ambulatory
velocity of individuals after using DAFOs daily for 4 weeks, which allowed the participants time
to adjust and become accustomed to the device. 9 Velocity was measured via motion analysis three
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times at the end of the 4 weeks while the participant wore DAFOs bilaterally and compared to
patient’s barefoot baseline and also while wearing another ankle foot orthotics after a 2-week
washout period. The order in which a participant wore a DAFO or the other type of ankle foot
orthotic included in the study was randomized. There was a 0% loss to follow up at the conclusion
of the research.9 The researchers used continuous data, which is provided in Table 2. The results
of this study show that patient’s ambulatory velocity minimally increased if one was wearing a
dynamic foot orthotic or if they were barefoot. Using ANOVA, examiners found that there were
no statistically significant changes in ambulatory velocity when comparing the DAFO and barefoot
conditions using a P ≤ 006 as being statistically significant but did not provide individual P-values.9
Table 2. – Ambulatory Velocity (m/s) at baseline and with DAFO use
Condition:
Mean and Standard Deviation
Baseline (Barefoot)
1.01 ± 0.6
DAFO
1.11 ± 0.6
Mean Change in Velocity
0.10 ± 0.0 (P ≤ 006)

Wren et al. directed a randomized controlled trial with crossover that looked at ambulatory
velocity of 10 children (40% male, 60% female) between 4-12 years old with differing baseline
GMFCS-88 scores against age matched controls while wearing custom fitted DAFOs, other
custom fitted orthotics and barefoot.10 Both orthotic types were worn for 4 weeks without a
washout period. As is shown in Table 1, the inclusion criteria included baseline gross motor
function scores of I-III and either a crouch or equinus pattern gait.10 The distribution of GMFCS88 baseline classifications is shown in Table 3. 4 of the subjects who were classified as GMFCS88 level III and used assistive devices as their baseline and were permitted to use them during the
testing. 10 There was 0% loss to follow up throughout the trial and participants reported no adverse
effects. The data was reported as continuous and is shown in Table 4. This research shows that
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there was a statistically significant increase (P = .006; CI: 95%) in ambulatory velocity when using
DAFOs than when compared to their barefoot baseline.
Table 3: Number of Participants based on GMFCS-88
Baseline Gross Motor
I
Function Classification Score
Classification Level
Walks without
Interpretation11
restrictions; some
limitations with
running/jumping
Number of Participants
6
Table 4: Mean Ambulatory Velocity (m/s)
Barefoot (Mean ± SD)
Velocity (m/s)
0.72 ± 0.34
Statistical Measures

II

III

Walks with
assistance from
surrounding and
/or crutches
0

Walks with
assistance of
walker and/or
crutches
4

DAFO (Mean ± SD)
0.78 ± 0.34

Mean Change
0.06 ± 0.00
P =.006 (CI: 95%)

Using a double blinded randomized controlled trial, Bjornson et al examined 23
participants with differing GMFCS-88 score baselines to evaluate any changes in GMFCS-88
scores when barefoot and while wearing bilateral DAFOs.12 Each participant had used bilateral
DAFO daily prior to participation in the research. DAFOs or placebo orthotics were applied to the
participant and covered with athletic wear to allow for blinding from a physical therapist scoring
each participant.12 Subjects ranged from 1.9 –7.3 years of age. Each participant was scored on 3
different activity categories using the GMFCS-88 scoring system: crawling/kneeling, standing,
and walking/running/jumping. Each category contains a certain number of specific tasks and
movements that patients are asked to complete. Continuous data was collected and the results of
the “walking/running/jumping” category are shown in Table 5. 12 This research shows that there
was an increase in the participants’ level of function in terms of running, jumping and walking.
The p-value and chi squared calculation demonstrate that the increase is statistically significant
and that participants demonstrating higher scores on the GMFCS-88 are not due to chance, but
instead due to an association between the intervention (DAFO use) and ambulation.
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Table 5: Average GMFCS-88 Scores for Walking/Running/Jumping
Condition
(Mean ± SD)
Barefoot
19.9 ± 17.7
DAFO
26.4 ± 23.6
Difference (DAFO – Barefoot)
6.5 ± 5.9
P- Value:
<.001
2
X
6.7
Unlike other medical treatments, in which treatments are invasive or absorbed via a
medication, dynamic ankle foot orthotics are noninvasive and external. Their effects are immediate
and the effectiveness is dependent on wearing the devices. As a result, none of the reviewed studies
reported any adverse effects or safety concerns.
DISCUSSION:
The content of this evidence based systematic review focused on if dynamic ankle foot
orthotics affect ambulatory function and speed of pediatric patients with spastic diplegic pattern
cerebral palsy. Orthotics, as a whole, are considered exempt from regulation by the Food and Drug
Administration.13 Instead, indications for the appliances originate directly from insurance
companies. Generally, dynamic foot orthotics are indicated for individuals with a plantar flexion
spasticity and contracture upon passive dorsiflexion.14 From the perspective of cerebral palsy,
DAFOs are indicated in ambulatory individuals who require ankle support due to weak dorsiflexor
muscles, but are able to plantarflex without assistance.8 There are no absolute contraindications
for the use of dynamic ankle foot orthotics as they will not cause harm to a patient, but they are
ineffective in certain cases, such as individuals with a “foot drop” that do not have ankle
contractures.13
Through researching the topic, there were a few study limitations that could have impacted
the review. One limitation revolved around the fact that there are many types of ankle foot orthotics
making selection of studies that met all criteria challenging. Additionally, each of the studies
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chosen had small sample sizes and none of them utilized patients between 14-18 years of age,
which would still be considered pediatric patients. As the age ranges of the selected studies
examined young children through adolescents, it may be difficult to generalize the results towards
teenagers. Larger sample sizes with a wider age range would provide more evidence about the
effects or lack thereof of DAFOs on ambulation in the pediatric spastic diplegic cerebral palsy
population.
CONCLUSION:
As a whole, the evidence shows that dynamic ankle foot orthotics have a positive impact
on ambulation velocity and functional ability in pediatric patients with spastic diplegic cerebral
palsy but further research is necessary to confirm the relationship. Both of the studies examining
ambulation velocity showed increases when wearing the orthoses, but only one study showed a
statistically significant increase.9,11 Smith et al, only used participants with a Gross Motor Function
Classification Score of I, which may have influenced the outcomes as these participants are the
highest functioning and may not benefit from the devices.9 Bjornson et al, proved a statistically
significant increase in the Gross Motor Function Classification System-88 score for the
walking/running/jumping category.12 While this is only one study showing significant
improvements in functional scoring, it is important for future research to be completed to further
validate this increase in ambulatory function. Additionally, it is important to examine more age
groups (older adolescents and young adults) to determine whether the effects are as profound as
they are in the young pediatric population.
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